Takeda Pharmaceutical Co Novice Eulerpool

Takeda Pharmaceutical Co Eulerpool News

Takeda Pharmaceutical Co Novice o delnici

Takeda Pharmaceutical Co spremljajo številni novinarji in vlagatelji po vsem svetu. Najnovejše Takeda Pharmaceutical Co novice zbiramo in objavljamo tukaj.

• 27. maj ·

  SeekingAlpha
  Arrowhead Pharmaceuticals: Hoping Something Sticks
• 26. maj ·

  SeekingAlpha
  Week In Review: Hengrui And Dearon Announce $7.2B In Drug Licensings
• 25. maj ·

  TalkMarkets
  Week In Review: Hengrui And Degron Announce $7.2 Billion In Drug Licensings
• 23. maj ·

  TipRanks
  Takeda Pharmaceutical: Navigating Patent Expiration with a Strong Pipeline and Anticipated Growth
• 23. maj ·

  Seeking Alpha
  ADHD diagnoses increasing, becoming an 'expanding public health concern': CDC
• 21. maj ·

  TipRanks
  Takeda Issues Correction on Financial Statements
• 20. maj ·

  Seeking Alpha
  Week In Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion Deal
• 20. maj ·

  SeekingAlpha
  Week In Review: Takeda Options Alzheimer's Therapy From AC Immune In $2.2 Billion Deal
• 17. maj ·

  InvestorPlace
  Google DeepMind CEO: ‘This Is the Next $100 Billion AI Business’
• 16. maj ·

  Yahoo
  Takeda Canada Inc. concludes Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for LIVTENCITY® (maribavir) for the treatment of adults with a post-transplant cytomegalovirus (CMV) infection